VH-244

N/A

Report date: 2025/01/26 15:47:14
NME

Base Information

Drug NameVH-244
Drug Alias NameOptimized RNA molecule (Virion Biotherapeutics)VH-244
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionImmunostimulantsVirus replication inhibitors
TargetsUpdating
Therapy Area/IndicationsInfluenza A virus infectionsRespirovirus InfectionsRespiratory Syncytial Virus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVirion Biotherapeutics
China Registration ClassN/A

Develop Information

Active CompaniesVirion Biotherapeutics
Inactive CompaniesN/A
Active IndicationsInfluenza A virus infectionsRespirovirus InfectionsRespiratory Syncytial Virus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A